Pay in 4 interest-free payments of $6.84 Learn more
Ships within 48 hours · Estimated delivery Oct 29 - Nov 3
A 2025 study published in JMIR Formative Research found that active subscribers on Second Natures GLP-1-supported programme lost an average of 19.1% of body weight at 12 months, with 77.7% achieving at least 10% weight loss
[It means] being able to get patients, who may have had to go through a stepwise approach or may not previously have qualified, those medications. 1 Semaglutides ability to provide weight loss and kidney improvements could influence patients preference for the drug over other agents that gain multiple indications in the future, explained Kaitlin ORourke, PharmD, BCPS, an advanced practice clinical pharmacist at Brigham and Womens Hospital in Boston, Massachusetts
Branded medications and compounded versions are not the same product
The STEP 1 trial, published in the New England Journal of Medicine, studied once-weekly semaglutide at 2.4mg in adults with overweight or obesity alongside lifestyle intervention
